Login
$BETR
$20.80 +$3.08 (17.38%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Assets
Cash and cash equivalents
Restricted cash
Short-term investments
Mortgage loans held for sale, at fair value
Loans held for investment (net of allowance for credit losses of $2,251 and $1,667 as of December 31, 2025 and 2024, respectively)
Other receivables, net
Property and equipment, net
Right-of-use assets
Internal use software and other intangible assets, net
Goodwill
Derivative assets
Prepaid expenses and other assets
Bifurcated derivative
Loan commitment asset
Assets held for sale and discontinued operations
Held-for-Sale
Discontinued Operations
Total assets held for sale and discontinued operations
Total Assets
Liabilities and Stockholders’ Equity
Liabilities
Warehouse lines of credit
Convertible note
Pre-Closing Bridge Notes
Corporate line of credit, net
Senior notes
Customer deposits
Accounts payable and accrued expenses (includes payables to related parties of $453 and $200)
Escrow payable and other customer accounts
Derivative liabilities, at fair value
Convertible preferred stock warrants
Derivative liabilities
Warrant and equity related liabilities, at fair value
Lease liabilities
Other liabilities
Liabilities held for sale and discontinued operations
Held-for-Sale
Discontinued Operations
Total liabilities held for sale and discontinued operations
Total Liabilities
Convertible preferred stock, $0.0001 par value; none as of December 31, 2023; 602,405,839 shares authorized, 332,314,737 shares issued and outstanding and $420,472 liquidation preference as of December 31, 2022
Total convertible preferred stock, $0.0001 par value; none as of December 31, 2023; 602,405,839 shares authorized, 332,314,737 shares issued and outstanding and $420,472 liquidation preference as of December 31, 2022
Stockholders’ Equity
Common stock $0.0001 par value; 66,000,000 shares authorized and 18,981,789 and 15,996,907 shares issued and outstanding
Total common stock $0.0001 par value; 66,000,000 shares authorized and 18,981,789 and 15,996,907 shares issued and outstanding
Notes receivable from stockholders
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive gain
Total Stockholders’ Equity
Total Liabilities and Stockholders’ Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support